The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Benchmarking population-based EGFR mutation testing in nonsquamous non-small cell lung cancer.
Carolyn Jane Shiau
No relevant relationships to disclose
Jesse Paul Babwah
No relevant relationships to disclose
Gilda Da Cunha Santos
Honoraria - Boehringer Ingelheim Canada
Jenna R Sykes
No relevant relationships to disclose
Scott L. Boerner
No relevant relationships to disclose
William R. Geddie
No relevant relationships to disclose
Cuihong Wei
No relevant relationships to disclose
Suzanne Kamel-Reid
Consultant or Advisory Role - Boehringer Ingelheim (U)
Honoraria - AstraZeneca
Research Funding - AstraZeneca; Boehringer Ingelheim
David M Hwang
No relevant relationships to disclose
Ming Sound Tsao
Honoraria - AstraZeneca; Boehringer Ingelheim; Roche